17Aug
UK Life Sciences and Healthcare Newsletter - August 2020: COVID-19 – How Have Listed Companies Fared?
COVID-19 has had a significant financial impact on many listed companies and, in recent months, there has been a marked increase in equity capital raises by listed companies. As at 22 July 2020, there have been over 100 secondary equity fundraisings in excess of £10 million on the Main Market and AIM since the COVID lockdown period began. Some have had to raise emergency capital, on short notice and often at significant discounts, whereas others have sought to shore up their balance sheets as...
By:
Dechert LLP
Source Url: https://www.jdsupra.com/legalnews/uk-life-sciences-and-healthcare-82301/
Related
After a three-month delay in implementation to prepare for compliance, employer deductions under the...
Read More >
Informed employers know they must pay non-exempt employee for all hours actually worked. If an emplo...
Read More >
As our economy’s uptick continues to favor buyers, developers often find large parcels of contiguou...
Read More >
On January 9, 2020, the National Institute of Statistics and Geography (INEGI by its acronym in Span...
Read More >
As COVID-19 continues to result in government shutdown orders, labor shortages, and increased lead t...
Read More >
Swift Acquisition Corp. v. Krauss, et al., Case No. 2019-0509-PAF (Del. Ch. Aug. 25, 2020)—The Dela...
Read More >